Piñol G, Rueda F, Martí F, Puig L, De Moragas J M
Servicio de Dermatología, Hospital de la Santa Creu i Sant Pau, Universidad Autónoma de Barcelona.
Med Cutan Ibero Lat Am. 1990;18(1):13-7.
A potential therapeutic role of minoxidil in fibrotic or sclerotic conditions, such as keloids, has been suggested on the basis of its reported ability to inhibit the proliferation of human dermal fibroblasts. We have studied the effect of minoxidil on 3H-deoxythymidine uptake in cultures of human dermal fibroblasts derived from lesional and non-lesional skin from patients with keloids. The effect of the addition of fetal bovine serum, plasma and growth factors (insulin, EGF, PDGF, FGF and beta-TGF) to the medium has also been studied. Minoxidil, at concentrations ranging from 500 to 1,000 microM., caused an increase in DNA synthesis, which was proportional to the initial degree of fibroblast activation. Concentrations higher than 1,000 microM. caused a cytotoxic effect. Some reservations arise on the potential therapeutic use of minoxidil in conditions characterized by increased fibroblast proliferation, given the narrow margin between activation of DNA synthesis and cytotoxicity we have found in our experimental model.
基于米诺地尔据报道具有抑制人皮肤成纤维细胞增殖的能力,有人提出它在瘢痕疙瘩等纤维化或硬化性疾病中可能具有治疗作用。我们研究了米诺地尔对来自瘢痕疙瘩患者病变皮肤和非病变皮肤的人皮肤成纤维细胞培养物中3H-脱氧胸苷摄取的影响。还研究了向培养基中添加胎牛血清、血浆和生长因子(胰岛素、表皮生长因子、血小板衍生生长因子、成纤维细胞生长因子和β-转化生长因子)的效果。浓度为500至1000微摩尔的米诺地尔可导致DNA合成增加,这与成纤维细胞的初始活化程度成正比。高于1000微摩尔的浓度会产生细胞毒性作用。鉴于在我们的实验模型中发现DNA合成激活与细胞毒性之间的差距很小,对于米诺地尔在以成纤维细胞增殖增加为特征的疾病中的潜在治疗用途存在一些疑虑。